1. Home
  2. BANX vs SMTI Comparison

BANX vs SMTI Comparison

Compare BANX & SMTI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

BANX

ArrowMark Financial Corp.

HOLD

Current Price

$20.42

Market Cap

191.0M

Sector

Finance

ML Signal

HOLD

Logo Sanara MedTech Inc.

SMTI

Sanara MedTech Inc.

HOLD

Current Price

$34.06

Market Cap

208.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BANX
SMTI
Founded
N/A
1982
Country
United States
United States
Employees
N/A
N/A
Industry
Trusts Except Educational Religious and Charitable
Medical/Dental Instruments
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
191.0M
208.2M
IPO Year
2013
2008

Fundamental Metrics

Financial Performance
Metric
BANX
SMTI
Price
$20.42
$34.06
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
$34.00
AVG Volume (30 Days)
31.6K
263.3K
Earning Date
01-01-0001
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
0.05
Revenue
N/A
$15,586,976.00
Revenue This Year
N/A
$17.31
Revenue Next Year
N/A
$12.48
P/E Ratio
N/A
$681.20
Revenue Growth
N/A
32.47
52 Week Low
$18.45
$16.05
52 Week High
$23.67
$35.70

Technical Indicators

Market Signals
Indicator
BANX
SMTI
Relative Strength Index (RSI) 66.23 82.75
Support Level $19.33 $20.47
Resistance Level $21.65 N/A
Average True Range (ATR) 0.24 1.01
MACD 0.05 0.84
Stochastic Oscillator 89.52 97.70

Price Performance

Historical Comparison
BANX
SMTI

About BANX ArrowMark Financial Corp.

ArrowMark Financial Corp is a non-diversified, closed-end management investment company. The Fund's objective is to provide stockholders with current income, and to a lesser extent capital appreciation. The company's investments in various portfolios such as debt securities, Trust Preferred and Preferred Securities, preferred securities, exchange-traded funds, money market funds and others.

About SMTI Sanara MedTech Inc.

Sanara MedTech Inc is a medical technology company focused on developing and commercializing technologies to improve clinical outcomes and reduce healthcare expenditures in the surgical market. It markets and sells soft tissue repair and bone fusion products for use in operating rooms and sterile environments. Its soft tissue repair products include CellerateRX Surgical Powder, a hydrolyzed collagen used in management of surgical wounds, and BIASURGE Surgical Solution, a sterile no-rinse solution for wound irrigation, while its bone fusion products include BiFORM Bioactive Moldable Matrix, an osteoconductive implant that supports bone growth, and ALLOCYTE Plus Viable Bone Matrix, a human allograft cellular bone matrix containing bone-derived progenitor cells and conformable bone fibers.

Share on Social Networks: